Rare Skin Blistering Condition Gets First Drug Approved

MedPage Today) — Credit: B.E.L.A. butterfly children

The FDA granted the first drug approval for dystrophic epidermolysis bullosa (DEB), a topical gene therapy that treats the blistering wounds it causes, the agency announced Friday.
The…
Read More